Chrono Nutrition (CN) Intervention Program in Gestational Diabetes Mellitus (CN)
Primary Purpose
GDM
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
dietary guidelines
Sponsored by
About this trial
This is an interventional prevention trial for GDM
Eligibility Criteria
Inclusion Criteria:
- GDM first screened in 24-32 week of prenancy
- singleton pregnancy
- GDM screened in "Rabin medical center"
- signing an informed consent
Exclusion Criteria:
- women with history of metabolic disorder such as dislipidemia, heart disease, cancer, type 1 diabetes, type 2 diabetes, hypertension, kidney disease,liver disease, thyroids disorder, cancer.
- women with history of fertility drug therapy such as IVF or progsterone
- women who work night shifts
- women who work in air crew
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
CNdiet
GDMdiet
Arm Description
CNdiet includes chrono nutritional dietary guidelines
GDMdiet includes regular GDM diet
Outcomes
Primary Outcome Measures
Offspring of participants with GDM with higher Chrono Biological score will be reported with higher birth weight (+100 gr) compared to offspring of participants with GDM with lower Chrono Biological score.
Secondary Outcome Measures
Offspring of participants with GDM with higher Chrono Biological score will be reported with higher birth weight above the 90 percentile compared to offspring of participants with GDM with lower Chrono Biological score.
Full Information
NCT ID
NCT02916667
First Posted
September 10, 2016
Last Updated
October 9, 2016
Sponsor
Rabin Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT02916667
Brief Title
Chrono Nutrition (CN) Intervention Program in Gestational Diabetes Mellitus
Acronym
CN
Official Title
Chrono Nutrition Intervention Program in Gestational Diabetes Mellitus
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Unknown status
Study Start Date
November 2016 (undefined)
Primary Completion Date
October 2017 (Anticipated)
Study Completion Date
December 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rabin Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Working hypothesis and aims:
To asses Chrono Biological factors during the third trimester of gestational diabetes melittus (GDM) with birth weight and related complications. The investigators hypothesize that participants with GDM pregnancies with higher Chrono Biologocal status will be ended with higher birth weight compared to participants with GDM pregnancies with lower status. In addition, the investigators hypothesize that the Chrono Nutritional intervention program will contribute to the reduction of the rate of birth weight above percentile 90 compared with the participants with GDM in the control group.
Detailed Description
Background: Many studies have linked pre-pregnancy obesity and the metabolic syndrome, with an increased risk of developing gestational diabetes mellitus (GDM). These factors are associate with increased risk of newborn obesity, insulin resistance and diabetes. Recently, studies have shown that the "Chrono-Biological" (CB) aspects need to be considered in this context. These factors are related to endogenous circadian clocks, which regulate many body functions depending upon cycle of light and darkness during a day of almost 24 hours. By tracks daily fluctuations in heart rate, blood pressure, hormone secretion and control of a variety of metabolic pathways. Factors that can affect the setting of the circadian clock may include; Change dark and light hours, consumptions of certain nutrients during the day and more.
Chronic rhythm disruption associated with the development of obesity, diabetes, and more. Factors such as "chrono-nutrition" (CN) have a significant impact on variations in circadian rhythms includes: meals program schedule, glucose, saturated fat, caffeine and alcohol intake, and the ratio of macronutrients. Intervention studies in adults who are obese and diabetes were able to reduce the impact of these disorders by changing the composition and schedule of meals that lead to weight loss and diabetes control. Moreover, Insomnia during pregnancy can be caused by disorders CB. Insomnia affects 30-40% of all pregnancies. Some sleep disorders can be worsening by pregnancy, particularly overweight. Currently, routine monitoring and treatment of women with GDM does not include screening for sleep disorders and CN factors.
Working hypothesis and aims: To asses CB factors during the third trimester of participants with GDM pregnancies with a weight of childbirth and related complications. The investigators hypothesize that participants with GDM pregnancies with higher CB status will be ended with higher birth weight compared to participants with GDM pregnancies with a lower status.
In addition, the investigators assume that the CN intervention program will contribute to reducing the rate of birth weight above the 90 percentile compared to control group.
Methods: In a prospective cohort study, n= 280, The investigators will review the obstetric outcomes and the impact of CB disorders and complications for mother and fetus, through questionnaires. In a clinical trial n=100, The investigators will assess the effect of CN intervention on birth weight in participants with GDM pregnancies.
Expected results: Based on the investigators preliminary research and literature, The investigators expected that due to the increasing prevalence of obesity and sleep disturbance among GDM pregnancies , and the feasibility of high interference CN factors in pregnancy, Therefore, it is important to examine the impact of CB factors on maternal and fetal.
The importance of the study: Since there is a high probability that GDM is exposed to the interference of CB factors which are not monitored during GDM, this unique study, is of great importance for understanding the potential impact of the CB factors on higher birth weight rates.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
GDM
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
280 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
CNdiet
Arm Type
Active Comparator
Arm Description
CNdiet includes chrono nutritional dietary guidelines
Arm Title
GDMdiet
Arm Type
Placebo Comparator
Arm Description
GDMdiet includes regular GDM diet
Intervention Type
Other
Intervention Name(s)
dietary guidelines
Intervention Description
dietary guidelines will include chrono- nutrition diet plan
Primary Outcome Measure Information:
Title
Offspring of participants with GDM with higher Chrono Biological score will be reported with higher birth weight (+100 gr) compared to offspring of participants with GDM with lower Chrono Biological score.
Time Frame
2 year
Secondary Outcome Measure Information:
Title
Offspring of participants with GDM with higher Chrono Biological score will be reported with higher birth weight above the 90 percentile compared to offspring of participants with GDM with lower Chrono Biological score.
Time Frame
2 year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
GDM first screened in 24-32 week of prenancy
singleton pregnancy
GDM screened in "Rabin medical center"
signing an informed consent
Exclusion Criteria:
women with history of metabolic disorder such as dislipidemia, heart disease, cancer, type 1 diabetes, type 2 diabetes, hypertension, kidney disease,liver disease, thyroids disorder, cancer.
women with history of fertility drug therapy such as IVF or progsterone
women who work night shifts
women who work in air crew
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
yoel MI toledano, MD
Phone
+972-546331268
Ext
ISRAEL
Email
yoelto@clalit.org.il
First Name & Middle Initial & Last Name or Official Title & Degree
amalia MI messika, RD
Phone
+972-528187913
Ext
ISRAEL
Email
amali.messika@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Moshe MI Hod, Prof
Organizational Affiliation
head of the division of maternal fetal medicine at the women's hospital at Rabin medical center Israel
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
24443392
Citation
Donnelly JM, Walsh JM, Byrne J, Molloy EJ, McAuliffe FM. Impact of maternal diet on neonatal anthropometry: a randomized controlled trial. Pediatr Obes. 2015 Feb;10(1):52-6. doi: 10.1111/j.2047-6310.2013.00216.x. Epub 2014 Jan 20.
Results Reference
background
PubMed Identifier
24500517
Citation
Hiersch L, Yogev Y. Impact of gestational hyperglycemia on maternal and child health. Curr Opin Clin Nutr Metab Care. 2014 May;17(3):255-60. doi: 10.1097/MCO.0000000000000030.
Results Reference
background
PubMed Identifier
23082214
Citation
Schellong K, Schulz S, Harder T, Plagemann A. Birth weight and long-term overweight risk: systematic review and a meta-analysis including 643,902 persons from 66 studies and 26 countries globally. PLoS One. 2012;7(10):e47776. doi: 10.1371/journal.pone.0047776. Epub 2012 Oct 17.
Results Reference
background
PubMed Identifier
24457570
Citation
Yogev Y, Hiersch L. Pregnancy: impact of maternal nutrition on intrauterine fetal growth. World Rev Nutr Diet. 2014;109:101-8. doi: 10.1159/000356110. Epub 2014 Jan 16. No abstract available.
Results Reference
background
PubMed Identifier
25815987
Citation
Asher G, Sassone-Corsi P. Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock. Cell. 2015 Mar 26;161(1):84-92. doi: 10.1016/j.cell.2015.03.015.
Results Reference
background
PubMed Identifier
22676899
Citation
Cagampang FR, Bruce KD. The role of the circadian clock system in nutrition and metabolism. Br J Nutr. 2012 Aug;108(3):381-92. doi: 10.1017/S0007114512002139. Epub 2012 Jun 8.
Results Reference
background
PubMed Identifier
24572815
Citation
Tahara Y, Shibata S. Chrono-biology, chrono-pharmacology, and chrono-nutrition. J Pharmacol Sci. 2014;124(3):320-35. doi: 10.1254/jphs.13r06cr. Epub 2014 Feb 27.
Results Reference
background
PubMed Identifier
24628249
Citation
Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci. 2014 Apr;1311:151-73. doi: 10.1111/nyas.12355. Epub 2014 Mar 14.
Results Reference
background
PubMed Identifier
23512957
Citation
Jakubowicz D, Barnea M, Wainstein J, Froy O. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity (Silver Spring). 2013 Dec;21(12):2504-12. doi: 10.1002/oby.20460. Epub 2013 Jul 2.
Results Reference
background
PubMed Identifier
22945608
Citation
O'Keeffe M, St-Onge MP. Sleep duration and disorders in pregnancy: implications for glucose metabolism and pregnancy outcomes. Int J Obes (Lond). 2013 Jun;37(6):765-70. doi: 10.1038/ijo.2012.142. Epub 2012 Sep 4.
Results Reference
background
PubMed Identifier
35525420
Citation
Messika A, Toledano Y, Hadar E, Shmuel E, Tauman R, Shamir R, Froy O. Relationship among chrononutrition, sleep, and glycemic control in women with gestational diabetes mellitus: a randomized controlled trial. Am J Obstet Gynecol MFM. 2022 Sep;4(5):100660. doi: 10.1016/j.ajogmf.2022.100660. Epub 2022 May 4. Erratum In: Am J Obstet Gynecol MFM. 2022 Aug 23;:100701.
Results Reference
derived
Learn more about this trial
Chrono Nutrition (CN) Intervention Program in Gestational Diabetes Mellitus
We'll reach out to this number within 24 hrs